TY - JOUR
T1 - Essential role of IFNβ and CD38 in TNFα-induced airway smooth muscle hyper-responsiveness
AU - Jain, Deepika
AU - Keslacy, Stefan
AU - Tliba, Omar
AU - Cao, Yang
AU - Kierstein, Sonja
AU - Amin, Kunjlata
AU - Panettieri, Reynold A.
AU - Haczku, Angela Franciska
AU - Amrani, Yassine
PY - 2008/7/10
Y1 - 2008/7/10
N2 - We recently identified autocrine interferon (IFN)β as a novel mechanism mediating tumor necrosis factor (TNF)α-induced expression of inflammatory genes in airway smooth muscle (ASM) cells, including CD38, known to regulate calcium signaling. Here, we investigated the putative involvement of IFNβ in regulating TNFα-induced airway hyper-responsiveness (AHR), a defining feature of asthma. Using our pharmacodynamic model to assess ex vivo AHR isolated murine tracheal rings, we found that TNFα-induced enhanced contractile responses to carbachol and bradykinin was abrogated by neutralizing anti-IFNβ antibody or in tracheal rings deficient in CD38. In cultured human ASM cells, where CD38 has been involved in TNFα-induced enhanced calcium signals to carbachol and bradykinin, we found that neutralizing anti-IFNβ prevented TNFα enhancing action only on carbachol responses but not to that induced by bradykinin. In a well-characterized model of allergic asthma (mice sensitized and challenged with Aspergillus fumigatus (Af)), we found heightened expression of both IFNβ and CD38 in the airways. Furthermore, allergen-associated AHR to methacholine, assessed by lung resistance and dynamic compliance, was completely suppressed in CD38-deficient mice, despite the preservation of airway inflammation. These data provide the first evidence that ASM-derived IFNβ and CD38 may play a significant role in the development of TNFα-associated AHR.
AB - We recently identified autocrine interferon (IFN)β as a novel mechanism mediating tumor necrosis factor (TNF)α-induced expression of inflammatory genes in airway smooth muscle (ASM) cells, including CD38, known to regulate calcium signaling. Here, we investigated the putative involvement of IFNβ in regulating TNFα-induced airway hyper-responsiveness (AHR), a defining feature of asthma. Using our pharmacodynamic model to assess ex vivo AHR isolated murine tracheal rings, we found that TNFα-induced enhanced contractile responses to carbachol and bradykinin was abrogated by neutralizing anti-IFNβ antibody or in tracheal rings deficient in CD38. In cultured human ASM cells, where CD38 has been involved in TNFα-induced enhanced calcium signals to carbachol and bradykinin, we found that neutralizing anti-IFNβ prevented TNFα enhancing action only on carbachol responses but not to that induced by bradykinin. In a well-characterized model of allergic asthma (mice sensitized and challenged with Aspergillus fumigatus (Af)), we found heightened expression of both IFNβ and CD38 in the airways. Furthermore, allergen-associated AHR to methacholine, assessed by lung resistance and dynamic compliance, was completely suppressed in CD38-deficient mice, despite the preservation of airway inflammation. These data provide the first evidence that ASM-derived IFNβ and CD38 may play a significant role in the development of TNFα-associated AHR.
KW - Airway smooth muscle
KW - Allergic asthma
KW - Calcium signaling
KW - Cytokine
KW - Hypercontractility
KW - Inflammation
UR - http://www.scopus.com/inward/record.url?scp=44349172373&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44349172373&partnerID=8YFLogxK
U2 - 10.1016/j.imbio.2007.12.002
DO - 10.1016/j.imbio.2007.12.002
M3 - Article
C2 - 18514752
AN - SCOPUS:44349172373
VL - 213
SP - 499
EP - 509
JO - Immunobiology
JF - Immunobiology
SN - 0171-2985
IS - 6
ER -